Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model
Background and aim: Resveratrol is a bioactive molecule used in dietary supplements and herbal medicines and consumed worldwide. Prior work showed that resveratrol's anti-atherogenic properties are mediated in part through the adenosine A2A receptor. The present study explores the potential con...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | Journal of Traditional and Complementary Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2225411022000062 |
| _version_ | 1828431384075567104 |
|---|---|
| author | Lora J. Kasselman Heather A. Renna Iryna Voloshyna Aaron Pinkhasov Irving H. Gomolin Isaac Teboul Joshua De Leon Steven E. Carsons Allison B. Reiss |
| author_facet | Lora J. Kasselman Heather A. Renna Iryna Voloshyna Aaron Pinkhasov Irving H. Gomolin Isaac Teboul Joshua De Leon Steven E. Carsons Allison B. Reiss |
| author_sort | Lora J. Kasselman |
| collection | DOAJ |
| description | Background and aim: Resveratrol is a bioactive molecule used in dietary supplements and herbal medicines and consumed worldwide. Prior work showed that resveratrol's anti-atherogenic properties are mediated in part through the adenosine A2A receptor. The present study explores the potential contribution of adenosine A2A receptor activation to neuroprotective action of resveratrol on cognitive deficits in a model of atherosclerosis-prone systemic lupus erythematosus. Experimental procedure: Using behavioral analysis (open field, static rod, novel object recognition) and QRT-PCR, this study measured working memory, anxiety, motor coordination, and expression of mRNA in the brain. Results and conclusion: Data indicate that resveratrol increases working memory, on average but not statistically, and shows a trend towards improved motor coordination (p = 0.07) in atherosclerosis-prone lupus mice. Additionally, resveratrol tends to increase mRNA levels of SIRT1, decrease vascular endothelial growth factor and CX3CL1 mRNA in the hippocampus. Istradefylline, an adenosine A2A receptor antagonist, antagonizes the effects of resveratrol on working memory (p = 0.04) and the expression of SIRT1 (p = 0.03), vascular endothelial growth factor (p = 0.04), and CX3CL1 (p = 0.03) in the hippocampus.This study demonstrates that resveratrol could potentially be a therapeutic candidate in the modulation of cognitive dysfunction in neuropsychiatric lupus, especially motor incoordination. Further human studies, as well as optimization of resveratrol administration, could confirm whether resveratrol may be an additional resource available to reduce the burden of cognitive impairment associated with lupus. Additionally, further studies need to address the role of A2A blockade in cognitive function among the autoimmune population. Section: 3. Dietary therapy/nutrients supplements. Taxonomy (classification by EVISE): autoimmunity, inflammation, neurology. |
| first_indexed | 2024-12-10T18:02:27Z |
| format | Article |
| id | doaj.art-a0b0d55390024b079734f8f3bef5eeae |
| institution | Directory Open Access Journal |
| issn | 2225-4110 |
| language | English |
| last_indexed | 2024-12-10T18:02:27Z |
| publishDate | 2022-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Traditional and Complementary Medicine |
| spelling | doaj.art-a0b0d55390024b079734f8f3bef5eeae2022-12-22T01:38:44ZengElsevierJournal of Traditional and Complementary Medicine2225-41102022-09-01125447454Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse modelLora J. Kasselman0Heather A. Renna1Iryna Voloshyna2Aaron Pinkhasov3Irving H. Gomolin4Isaac Teboul5Joshua De Leon6Steven E. Carsons7Allison B. Reiss8NYU Long Island School of Medicine, Foundations of Medicine, Mineola, NY, USA; Corresponding author. NYU Long Island School of Medicine, Foundations of Medicine, 222 Station Plaza, Mineola, NY, 11501, USA.NYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USANYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USANYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USANYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USANYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USANYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USANYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USANYU Winthrop Hospital, Winthrop Research Institute, Department of Medicine, Mineola, NY, USABackground and aim: Resveratrol is a bioactive molecule used in dietary supplements and herbal medicines and consumed worldwide. Prior work showed that resveratrol's anti-atherogenic properties are mediated in part through the adenosine A2A receptor. The present study explores the potential contribution of adenosine A2A receptor activation to neuroprotective action of resveratrol on cognitive deficits in a model of atherosclerosis-prone systemic lupus erythematosus. Experimental procedure: Using behavioral analysis (open field, static rod, novel object recognition) and QRT-PCR, this study measured working memory, anxiety, motor coordination, and expression of mRNA in the brain. Results and conclusion: Data indicate that resveratrol increases working memory, on average but not statistically, and shows a trend towards improved motor coordination (p = 0.07) in atherosclerosis-prone lupus mice. Additionally, resveratrol tends to increase mRNA levels of SIRT1, decrease vascular endothelial growth factor and CX3CL1 mRNA in the hippocampus. Istradefylline, an adenosine A2A receptor antagonist, antagonizes the effects of resveratrol on working memory (p = 0.04) and the expression of SIRT1 (p = 0.03), vascular endothelial growth factor (p = 0.04), and CX3CL1 (p = 0.03) in the hippocampus.This study demonstrates that resveratrol could potentially be a therapeutic candidate in the modulation of cognitive dysfunction in neuropsychiatric lupus, especially motor incoordination. Further human studies, as well as optimization of resveratrol administration, could confirm whether resveratrol may be an additional resource available to reduce the burden of cognitive impairment associated with lupus. Additionally, further studies need to address the role of A2A blockade in cognitive function among the autoimmune population. Section: 3. Dietary therapy/nutrients supplements. Taxonomy (classification by EVISE): autoimmunity, inflammation, neurology.http://www.sciencedirect.com/science/article/pii/S2225411022000062Systemic lupus erythematosusCognitionNeurolupusNutraceuticalCardiovascular |
| spellingShingle | Lora J. Kasselman Heather A. Renna Iryna Voloshyna Aaron Pinkhasov Irving H. Gomolin Isaac Teboul Joshua De Leon Steven E. Carsons Allison B. Reiss Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model Journal of Traditional and Complementary Medicine Systemic lupus erythematosus Cognition Neurolupus Nutraceutical Cardiovascular |
| title | Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model |
| title_full | Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model |
| title_fullStr | Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model |
| title_full_unstemmed | Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model |
| title_short | Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model |
| title_sort | cognitive changes mediated by adenosine receptor blockade in a resveratrol treated atherosclerosis prone lupus mouse model |
| topic | Systemic lupus erythematosus Cognition Neurolupus Nutraceutical Cardiovascular |
| url | http://www.sciencedirect.com/science/article/pii/S2225411022000062 |
| work_keys_str_mv | AT lorajkasselman cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT heatherarenna cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT irynavoloshyna cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT aaronpinkhasov cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT irvinghgomolin cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT isaacteboul cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT joshuadeleon cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT stevenecarsons cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel AT allisonbreiss cognitivechangesmediatedbyadenosinereceptorblockadeinaresveratroltreatedatherosclerosispronelupusmousemodel |